Nasdaq Stocks

The global pharmaceutical industry is in a tight spot because of the Coronarivus outbreak in China that is making its presence felt across drug manufacturing units and supply chains. After all, pharma giants heavily reliant on this Asian country for active pharmaceutical ingredi

First Solar Inc. FSLR reported fourth-quarter 2019 adjusted earnings of $2.02 per share, which missed the Zacks Consensus Estimate of $2.79 by 27.6%.

Diana Shipping (DSX) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.

Pilgrim's Pride Corporation PPC reported fourth-quarter 2019 results, with the top and the bottom line improving year over year. The upside can be attributed to improved performance in the United States, Mexico and European operations. However, earnings lagged the Zacks Consensu

Jazz Pharmaceuticals PLC JAZZ is scheduled to report fourth-quarter 2019 results on Feb 25, after market close. In the last reported quarter, the company delivered a positive earnings surprise of 14.21%.

Apache Corporation APA is scheduled to release fourth-quarter 2019 results on Wednesday Feb 26, after the closing bell.

The coronavirus is once again front and center for investors today with stocks in Asia closing mostly in the red except for the major Chinese indices on word that the return to work is accelerating in the major foreign trade provides.

Per an article by The New York Times, Wells Fargo & Company WFC is nearing settlement with the U.S. Department of Justice and the Securities and Exchange Commission over matters of fake account openings scandal, auto lending probes and mortgage businesses.

Allison Transmission Holdings Inc.’s ALSN fourth-quarter 2019 earnings came in at 85 cents per share, beating the Zacks Consensus Estimate of 72 cents. It delivered better-than-expected results on the back of higher-than-anticipated revenues from the North America On-Highway,

U.S. stock futures are falling Friday as worrying coronavirus headlines keep trickling in and investors appear unwilling to hold riskier assets like equities going into the weekend.

The stock market’s reaction to the coronarivus is based on what happened with SARS, but China’s economic is much bigger than it was in 2003.

Over the past two weeks, its been a topsy-turvy ride for equities. While many astute investors had been expecting a pullback in equities after a more than 30% rally, very few actually expected the reason would be concerns surrounding a virus.

FTI Consulting, Inc. FCN is scheduled to report fourth-quarter 2019 results on Feb 25, before the opening bell.

Syneos Health Inc. SYNH reported fourth-quarter 2019 adjusted earnings per share (EPS) of $1.03, which beat the Zacks Consensus Estimate by 1.9%. The metric also improved 8.4% from the year-ago figure.Reported EPS was 86 cents, marking an improvement of 9.5% from the year-ago n

Reliance Steel & Aluminum Co. RS posted profits of $165.6 million or $2.44 per share in the fourth quarter of 2019, up around 94% from $85.6 million or $1.22 in the year-ago quarter. Earnings per share topped the Zacks Consensus Estimate of $1.71.Reliance Steel recorded net

European stocks slipped on Friday, as worries about the coronavirus outbreak spreading beyond China offset indications the economy is improving.

South Africa's National Treasury will try to trim its swollen budget deficit by raising revenue through personal income and excise tax hikes at its budget review on Feb. 26, a Reuters poll found on Friday.

U.S. investors' persistent optimism that the coronavirus will be short-lived is being challenged by increasing evidence that the virus has spread beyond China's borders.

Goldman Sachs BDC (GSBD) came out with quarterly earnings of $0.48 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.56 per share a year ago. These figures are adjusted for non-recurring items.

Select Medical (SEM) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.20 per share a year ago. These figures are adjusted for non-recurring items.